Nasrollah Erfani - Concepedia

Author

Nasrollah Erfani

Shiraz University of Medical Sciences ORCID

Also Known As

Erfani, Nasrollah, N Erfani, N. Erfani, Nasrallah Erfani, Nasrolah ERFANİ, Nasrolah Erfani, Nasrolla Erfani, Nasrollah Erfani, Nasroolah Erfani, Nasroollah Erfani

168

Publications

2.8K

Citations

H-Index

115

Concepts

All Affiliations

Shiraz University of Medical Sciences Shiraz University Fasa University of Medical Sciences

About

Nasrollah Erfani is an author at Shiraz University of Medical Sciences specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	34	1.6K
2	Natural Sciences	2	2	53
3	Public Health	2	2	55
4	Engineering	1	1	41
5	Health Sciences	1	1	46

Nasrollah Erfani

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC) Nasrollah Erfani, Shayesteh Mofakhami Mehrabadi, Seiyed Mohammad Ali Ghayumi, Lung Cancer Cancer ImmunosurveillanceT-regulatory CellImmunologyRegulatory T CellsMetastatic Stage	2012	154
Structural vaccinology considerations for in silico designing of a multi-epitope vaccine Manica Negahdaripour, Navid Nezafat, Mahboobeh Eslami, Infection Genetics and Evolution VaccinologyVaccinationCross-protectionReverse VaccinologyVaccine Target	2017	134
Vaccinomics approach for developing multi-epitope peptide pneumococcal vaccine Hesam Dorosti, Mahboobeh Eslami, Manica Negahdaripour, Journal of Biomolecular Structure and Dynamics	2019	124
Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL-10 and TGF-β1 and upregulate expression of regulatory molecules on T cells: Do they protect breast cancer cells from the immune response? Mahboobeh Razmkhah, Mansooreh Jaberipour, Nasrollah Erfani, Cellular Immunology T CellsMedicineStem Cell EngineeringImmunologyImmune Regulation	2010	114
Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer Nasrollah Erfani, Mahbobeh Razmkhah, Abdolrasoul Talei, Cancer Genetics and Cytogenetics Breast OncologyImmunologyPathologyBreast CancerImmunotherapy	2006	84
Synthesis, spectroscopic characterization, structural studies and antibacterial and antitumor activities of diorganotin complexes with 3-methoxysalicylaldehyde thiosemicarbazone Marzieh Khandani, Tahereh Sedaghat, Nasrollah Erfani, Journal of Molecular Structure Medicinal ChemistrySpectroscopic CharacterizationDiorganotin ComplexesMolecular ComplexStructural Studies	2013	80
Immunoinformatics-aided design of a potential multi-epitope peptide vaccine against Leishmania infantum Bahareh Vakili, Mahboobeh Eslami, Gholamreza Hatam, International Journal of Biological Macromolecules VaccinationCross-protectionLeishmania InfantumMedicineVaccine Target	2018	78
A novel HPV prophylactic peptide vaccine, designed by immunoinformatics and structural vaccinology approaches Manica Negahdaripour, Mahboobeh Eslami, Navid Nezafat, Infection Genetics and Evolution VaccinationVaccine DevelopmentHuman Papillomavirus VaccinesVaccine TargetImmunology	2017	77
<i>CTLA‐4</i> gene promoter and exon 1 polymorphisms in Iranian patients with gastric and colorectal cancers Abolghasem Hadinia, Seyed Vahid Hossieni, Nasrollah Erfani, Journal of Gastroenterology and Hepatology	2007	69
Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodes Zahra Faghih, Nasrollah Erfani, Mohammad Reza Haghshenas, Immunology Letters Cd4+ Lymphocyte SubsetsLymphoid NeoplasiaCancer ImmunosurveillanceBreast Cancer TumorImmunology	2013	67

Page 1